Search Results - "Sabino Strippoli"

Refine Results
  1. 1
  2. 2

    The β-adrenergic receptor antagonist propranolol offsets resistance mechanisms to chemotherapeutics in diverse sarcoma subtypes: a pilot study by Porcelli, Letizia, Garofoli, Marianna, Di Fonte, Roberta, Fucci, Livia, Volpicella, Mariateresa, Strippoli, Sabino, Guida, Michele, Azzariti, Amalia

    Published in Scientific reports (26-06-2020)
    “…Standard chemotherapy for soft tissue sarcomas has shown limited efficacy. Here, we sought to evaluate whether β-adrenergic receptor (β-AR) signalling…”
    Get full text
    Journal Article
  3. 3

    A deep learning model based on whole slide images to predict disease-free survival in cutaneous melanoma patients by Comes, Maria Colomba, Fucci, Livia, Mele, Fabio, Bove, Samantha, Cristofaro, Cristian, De Risi, Ivana, Fanizzi, Annarita, Milella, Martina, Strippoli, Sabino, Zito, Alfredo, Guida, Michele, Massafra, Raffaella

    Published in Scientific reports (27-11-2022)
    “…The application of deep learning on whole-slide histological images (WSIs) can reveal insights for clinical and basic tumor science investigations. Finding…”
    Get full text
    Journal Article
  4. 4

    Case Report: Autoimmune Pemphigus Vulgaris in a Patient Treated With Cemiplimab for Multiple Locally Advanced Cutaneous Squamous Cell Carcinoma by Buquicchio, Rosalba, Mastrandrea, Valentina, Strippoli, Sabino, Quaresmini, Davide, Guida, Michele, Filotico, Raffaele

    Published in Frontiers in oncology (23-08-2021)
    “…Pemphigus vulgaris (PV) is a rare and severe autoimmune blistering disorder affecting the skin and mucous membranes, characterized by the production of…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Is immunohistochemistry of BRAF V600E useful as a screening tool and during progression disease of melanoma patients? by Schirosi, Laura, Strippoli, Sabino, Gaudio, Francesca, Graziano, Giusi, Popescu, Ondina, Guida, Michele, Simone, Giovanni, Mangia, Anita

    Published in BMC cancer (18-11-2016)
    “…In clinical practice the gold standard method to assess BRAF status in patients with metastatic melanoma is based on molecular assays. Recently, a…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Proteomic profile and in silico analysis in metastatic melanoma with and without BRAF mutation by Garrisi, Vito Michele, Strippoli, Sabino, De Summa, Simona, Pinto, Rosamaria, Perrone, Antonella, Guida, Gabriella, Azzariti, Amalia, Guida, Michele, Tommasi, Stefania, Stefania, Tommasi

    Published in PloS one (01-12-2014)
    “…Selective inhibitors of BRAF, vemurafenib and dabrafenib are the standard of care for metastatic melanoma patients with BRAF V600, while chemotherapy continued…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20